Agnieszka Klimek-Abercrombie

Agnieszka Klimek-Abercrombie, PhD MBA, is an accomplished professional in the pharmaceutical industry with extensive experience at Novo Nordisk since June 2012, where roles include Global Associate Commercial Project Director for the SOUL CVOT of Rybelsus and various positions in Medical Affairs focusing on cardiovascular disease and diabetes. Agnieszka has a strong background in medical leadership, KOL engagement, and evidence generation, having supported major product launches such as Ozempic and Rybelsus. Prior to Novo Nordisk, Agnieszka held a postdoctoral research fellowship at the PROOF Centre of Excellence, focusing on biomarker development, and served as an instructor at The University of British Columbia. Agnieszka holds an MBA in Management of Technology from Simon Fraser University, a PhD in Pathology from The University of British Columbia, and a BSc in Biology from the University of Victoria.